fxs_header_sponsor_anchor

News

AUD/USD: Back below 0.5750 amid fresh US dollar strength

  • AUD/USD fails to holds onto recovery gains.
  • Coronavirus updates renew the US dollar buying amid fears of widespread contagion.
  • PBOC rate decision can offer intermediate moves, Remdesivir, COVID-19 will keep the driver’s seat.

AUD/USD extends the pullback from 0.5900 while declining to 0.5725 at the start of Friday’s Asian session. While efforts from the US Fed to shore the US dollar supplies dragged the greenback earlier, fresh coronavirus (COVID-19) updates help it regain the strength.

Global central banks continue to fight against COVID-19…

Be it the RBA, ECB, BOJ or the Fed, not to forget the BOE and Asian banks, all at the helm keep pumping their respective monetary system and or avail swaps to fight against the deadly virus.

The RBA’s 25 basis points (bps) rate cut and a QE seemed to have escalated the market’s worries the previous day. “The RBA cut the cash rate 0.25% yesterday and announced that they would target the 3-year ACGB rate at 0.25% and buy bonds in unlimited volume ‘across the yield curve’. Unfortunately, the market didn’t get the last part of that message straight away and hit the panic button, with the 10-year Australian Government bond yield rising over 100bps in less than a minute,” said the Australia and New Zealand Banking Group (ANZ).

On the other hand, the Fed makes swap arrangements with nine more central banks to cut the USD shortage at the time of the market’s rush to hoard the greenback.

In the case of coronavirus updates, NYC Mayor De Blasio recently signaled the shortage of medical supplies in 2-3 weeks while seeking military help to fight the pandemic. Further, news that the Brexit negotiators of the UK and the EU are both infected with the deadly virus has also renewed the risk-off.

As a result, Wall Street’s mildly positive closing fails to carry the mark on the US 10-year treasury yields that are down one basis point to 1.158%.

Given the lack of major data/events on the economic calendar, except for the People’s Bank of China’s (PBOC) rate decision, investors will keep eyes on the disease updates. News that a cure has been tested, Remdesivir, gives the hope to overcome the pandemic.

Technical Analysis

A descending trend line connecting lows marked between March 09 and 16 offers immediate resistance around 0.5950. On the downside, 0.5600 and the recent low near 0.5510 will please sellers during further downside.

Additional important levels

Overview
Today last price 0.5735
Today Daily Change -39 pips
Today Daily Change % -0.68%
Today daily open 0.5774
 
Trends
Daily SMA20 0.645
Daily SMA50 0.6648
Daily SMA100 0.6758
Daily SMA200 0.6804
 
Levels
Previous Daily High 0.6029
Previous Daily Low 0.5701
Previous Weekly High 0.6686
Previous Weekly Low 0.6122
Previous Monthly High 0.6775
Previous Monthly Low 0.6434
Daily Fibonacci 38.2% 0.5826
Daily Fibonacci 61.8% 0.5904
Daily Pivot Point S1 0.564
Daily Pivot Point S2 0.5507
Daily Pivot Point S3 0.5313
Daily Pivot Point R1 0.5968
Daily Pivot Point R2 0.6162
Daily Pivot Point R3 0.6296

 

 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2026 FOREXSTREET S.L., All rights reserved.